PATENT CLAIM ANALYSIS

Application Number: 15895333
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "451000"]

Abstract:
Described herein are pharmaceutical compositions providing enhanced bioavailability of polyunsaturated fatty acids and methods of manufacturing the same. In particular, described herein are pharmaceutical compositions comprising soft enteric capsules that provide enhanced bioavailability of omega-3 polyunsaturated fatty acids. The oral pharmaceutical compositions described herein are useful as nutritional supplements or for the treatment of cardiovascular-related diseases, such as hyper dyslipidemia and moderate to high triglyceride levels.

Claim (Index 82):
The composition of  claim 81 , wherein the enteric polymer is an acrylic and methacrylic acid copolymer; the plasticizer is glycerol or triethyl citrate or a combination thereof; the alkali neutralizing agent is ammonium hydroxide or sodium hydroxide or a combination thereof; and the solvent is water.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 88.0
- Lexical Diversity: 1.47917
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14749671', '14527201', '15895344', '15718531', '15404368']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7865301243645377
- 35 USC 102 Novelty (BERT): 0.61917320179576
- Combined Prediction Score: 0.76979443210766
- Mean Citation Score: 430.508002
- Max Citation Score: 587.3669
- Similarity Product: 512.6530907450734

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test